J0693 HCPCS Level II code: Injection, cefiderocol, 5 mg
CMS terminated J0693: its last date of service was Sep 30, 2021. It stays here for looking up older claims; newer services need a current code.
Official description
J0693Injection, cefiderocol, 5 mg
Short description: Inj., cefiderocol, 5 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0693 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2021
- Terminated after
- Sep 30, 2021
Where J0693 sits
- 1J codesDrugs administered other than orally
- 2Terminated J0693Injection, cefiderocol, 5 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J0693 still valid?
No. CMS terminated J0693; its last date of service was Sep 30, 2021. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J0693?
CMS lists J0693’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0693
All J codesJ0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mgJ0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mgJ0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mgJ0690Injection, cefazolin sodium, 500 mgJ0691Injection, lefamulin, 1 mgJ0692Injection, cefepime hydrochloride, 500 mgJ0694Injection, cefoxitin sodium, 1 gmJ0695Injection, ceftolozane 50 mg and tazobactam 25 mgJ0696Injection, ceftriaxone sodium, per 250 mgJ0697Injection, sterile cefuroxime sodium, per 750 mgJ0698Injection, cefotaxime sodium, per gmJ0699Injection, cefiderocol, 10 mg